Qiu YY - Search Results

1

Anti-tumor activity and apoptosis-regulation mechanisms of bufalin in various cancers: new hope for cancer patients.

Yin PH, Liu X, Qiu YY, Cai JF, Qin JM, Zhu HR, Li Q. Yin PH, et al. Among authors: qiu yy. Asian Pac J Cancer Prev. 2012;13(11):5339-43. doi: 10.7314/apjcp.2012.13.11.5339. Asian Pac J Cancer Prev. 2012. PMID: 23317181 Free article. Review.

2

MicroRNA-497 and bufalin act synergistically to inhibit colorectal cancer metastasis.

Qiu YY, Hu Q, Tang QF, Feng W, Hu SJ, Liang B, Peng W, Yin PH. Qiu YY, et al. Tumour Biol. 2014 Mar;35(3):2599-606. doi: 10.1007/s13277-013-1342-6. Epub 2013 Dec 29. Tumour Biol. 2014. PMID: 24375248

3

Bufalin-loaded mPEG-PLGA-PLL-cRGD nanoparticles: preparation, cellular uptake, tissue distribution, and anticancer activity.

Yin P, Wang Y, Qiu Y, Hou L, Liu X, Qin J, Duan Y, Liu P, Qiu M, Li Q. Yin P, et al. Int J Nanomedicine. 2012;7:3961-9. doi: 10.2147/IJN.S32063. Epub 2012 Jul 27. Int J Nanomedicine. 2012. PMID: 22888239 Free PMC article.

4

Norcantharidin inhibits tumor angiogenesis via blocking VEGFR2/MEK/ERK signaling pathways.

Zhang L, Ji Q, Liu X, Chen X, Chen Z, Qiu Y, Sun J, Cai J, Zhu H, Li Q. Zhang L, et al. Cancer Sci. 2013 May;104(5):604-10. doi: 10.1111/cas.12120. Epub 2013 Mar 20. Cancer Sci. 2013. PMID: 23363445 Free PMC article.

5

Ras/ERK signaling pathway is involved in curcumin-induced cell cycle arrest and apoptosis in human gastric carcinoma AGS cells.

Cao AL, Tang QF, Zhou WC, Qiu YY, Hu SJ, Yin PH. Cao AL, et al. Among authors: qiu yy. J Asian Nat Prod Res. 2015;17(1):56-63. doi: 10.1080/10286020.2014.951923. Epub 2014 Dec 10. J Asian Nat Prod Res. 2015. PMID: 25492214

6

Bufalin reverses ABCB1-mediated drug resistance in colorectal cancer.

Yuan ZT, Shi XJ, Yuan YX, Qiu YY, Zou Y, Liu C, Yu H, He X, Xu K, Yin PH. Yuan ZT, et al. Among authors: qiu yy. Oncotarget. 2017 Jul 18;8(29):48012-48026. doi: 10.18632/oncotarget.18225. Oncotarget. 2017. PMID: 28624793 Free PMC article.

7

Increasing the anticancer performance of bufalin (BUF) by introducing an endosome-escaping polymer and tumor-targeting peptide in the design of a polymeric prodrug.

Shi XJ, Qiu YY, Yu H, Liu C, Yuan YX, Yin PH, Liu T. Shi XJ, et al. Among authors: qiu yy. Colloids Surf B Biointerfaces. 2018 Jun 1;166:224-234. doi: 10.1016/j.colsurfb.2018.03.024. Epub 2018 Mar 19. Colloids Surf B Biointerfaces. 2018. PMID: 29602078

8

Reversal of P-gp-mediated multidrug resistance in colon cancer by cinobufagin.

Yuan Z, Shi X, Qiu Y, Jia T, Yuan X, Zou Y, Liu C, Yu H, Yuan Y, He X, Xu K, Yin P. Yuan Z, et al. Oncol Rep. 2017 Mar;37(3):1815-1825. doi: 10.3892/or.2017.5410. Epub 2017 Jan 30. Oncol Rep. 2017. PMID: 28184922

9

Bufalin reverses acquired drug resistance by inhibiting stemness in colorectal cancer cells.

Sun J, Xu K, Qiu Y, Gao H, Xu J, Tang Q, Yin P. Sun J, et al. Oncol Rep. 2017 Sep;38(3):1420-1430. doi: 10.3892/or.2017.5826. Epub 2017 Jul 17. Oncol Rep. 2017. PMID: 28731184 Free PMC article.

10

Bufalin-loaded vitamin E succinate-grafted-chitosan oligosaccharide/RGD conjugated TPGS mixed micelles demonstrated improved antitumor activity against drug-resistant colon cancer.

Yuan Z, Yuan Y, Han L, Qiu Y, Huang X, Gao F, Fan G, Zhang Y, Tang X, He X, Xu K, Yin P. Yuan Z, et al. Int J Nanomedicine. 2018 Nov 15;13:7533-7548. doi: 10.2147/IJN.S170692. eCollection 2018. Int J Nanomedicine. 2018. PMID: 30532537 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

176 results

Search Page

Filters